Loading clinical trials...
Loading clinical trials...
To evaluate the impact of induction of labour at 38 weeks with the induction of labour at 40 weeks in women with insulin dependent gestational diabetes mellitus on maternal and fetal outcome.
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
Medical University of Vienna
NCT07517406 · Gestational Diabetes Mellitus (GDM), Pregnancy Complications, and more
NCT06988306 · Diabetes Mellitus, Gestational Diabetes Mellitus (GDM)
NCT06548828 · Gestational Diabetes Mellitus in Pregnancy, Glucose Intolerance During Pregnancy, and more
NCT06648174 · Gestational Diabetes Mellitus, Continuous Glucose Monitoring
NCT06948825 · Weight Loss, Gestational Diabetes Mellitus in Pregnancy, and more
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions